Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature
Authors:
- 8 April 2008
- journal article
- review article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 24 (5) , 1459-1472
Abstract
Objectives: To investigate the relationship between time spent in the recommended target International Normalised Ratio (INR) range and the setting and intensity of anticoagulant monitoring, in both treatment-experienced and treatment-naïve atrial fibrillation (AF) patients receiving oral anticoagulation (OAC) therapy for the prevention of ischaemic stroke.Research design and methods: Systematic review of published studies on participants with atrial fibrillation on anticoagulation therapy. We compared frequent monitoring (well-controlled, according to a strict protocol) versus infrequent monitoring (frequency representative of routine clinical practice), specialised care versus usual care, and naïve versus prior anticoagulant use. Meta-analysis was performed using a random effects model.Results: 36 studies were included, 22 (primary data) of AF patients managed in line with the consensus guidelines target INR range of 2.0–3.0, and 14 studies (secondary data) of mixed patient groups, including AF...Keywords
This publication has 35 references indexed in Scilit:
- Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trialThe Lancet, 2006
- Effect of Study Setting on Anticoagulation ControlChest, 2006
- Self management of oral anticoagulation: randomised trialBMJ, 2005
- Warfarin Anticoagulation and Outcomes in Patients With Atrial FibrillationChest, 2004
- Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinicClinical Therapeutics, 2004
- Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trialThe Lancet, 2003
- American Heart Association/American College of Cardiology Foundation Guide to Warfarin TherapyCirculation, 2003
- A randomized controlled trial of shared care versus routine care for patients receiving oral anticoagulant therapyJournal of Internal Medicine, 2002
- Relationship Between Test Frequency and Outcomes of Anticoagulation: A Literature Review and Commentary with Implications for the Design of Randomized Trials of Patient Self-ManagementJournal of Thrombosis and Thrombolysis, 2000
- Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart ValvesNew England Journal of Medicine, 1995